Cargando…
68 Metformin prevents the diagnosis of Long Covid in phase 3 trial of early treatment.
OBJECTIVES/GOALS: Chronic or new symptoms after infection with severe-acute-respiratory-coronavirus-2 (SARS-CoV-2) has been termed post-acute sequelae of Covid-19 (PASC) or Long Covid. Our objective is to present results from COVID-OUT, a phase 3 double-blind, randomized controlled trial of early ou...
Autores principales: | Bramante, Carolyn, Wirtz, Esteban, Buse, John, Boulware, David, Nicklas, Jacinda, Odde, David, Cohen, Ken, Puskarich, Michael, Tignanelli, Christopher, Klatt, Nichole, Leibovitz, David, Belani, Hrishikesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129569/ http://dx.doi.org/10.1017/cts.2023.154 |
Ejemplares similares
-
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up
por: Bramante, Carolyn T., et al.
Publicado: (2022) -
Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2
por: Avula, Nandini, et al.
Publicado: (2023) -
Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic Symptoms
por: Bramante, Carolyn T, et al.
Publicado: (2022) -
57 Utility of Digital Phenotyping in Big Data to Answer Clinical Questions: Puberty as a Transdisciplinary Science Case Example
por: Schnabel, David J., et al.
Publicado: (2023) -
67 Lipid metabolism and synthesis pathway analysis of Sigma-2 Receptor/TMEM97 in breast cancer cells
por: Riad, Aladdin, et al.
Publicado: (2023)